Europe remains a large but under-penetrated destination for Indian drugmakers. Data from the Pharmaceuticals Export Promotion ...
The so-called “mother of all deals” lowers import tariffs on European pharma exports from 11% to zero and also eliminates ...
Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the ...
In an agreement that seemingly bodes well for the flow of pharmaceuticals between the two regions, the EU and India on Monday agreed to a sweeping free trade agreement that the European bloc has ...
The European Union (EU) has agreed to offer Indian pharmaceutical and medical devices companies preferential access to EU ...
The proposed agreement aims to cut tariffs on medicines and medical devices, potentially lowering healthcare costs, while ...
India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN), a ...
Export-focused stocks jump on optimism around Europe exposure, as analysts suggest textiles, pharmaceuticals and chemicals ...
Jan 28 (Reuters) - India's Gland Pharma reported a nearly 28% jump in third-quarter profit on Wednesday, boosted by strong sales in the key European and U.S. markets. The Hyderabad-based company ...
ABP News on MSN
What India Inc can learn from pharma’s TRIPS journey as global tariffs rise: Economic Survey
India Inc can draw inspiration from the domestic pharma industry, which transformed itself in the aftermath of the TRIPS ...
Jan 23 () - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said on Friday that it has received regulatory approval to manufacture and sell generic semaglutide in India.
Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results